Literature DB >> 25733239

Thromboxane prostanoid receptors enhance contractions, endothelin-1, and oxidative stress in microvessels from mice with chronic kidney disease.

Cheng Wang1, Zaiming Luo1, Donald Kohan1, Anton Wellstein1, Pedro A Jose1, William J Welch1, Christopher S Wilcox1, Dan Wang2.   

Abstract

Cardiovascular disease is frequent in chronic kidney disease and has been related to angiotensin II, endothelin-1 (ET-1), thromboxane A2, and reactive oxygen species (ROS). Because activation of thromboxane prostanoid receptors (TP-Rs) can generate ROS, which can generate ET-1, we tested the hypothesis that chronic kidney disease induces cyclooxygenase-2 whose products activate TP-Rs to enhance ET-1 and ROS generation and contractions. Mesenteric resistance arterioles were isolated from C57/BL6 or TP-R+/+ and TP-R-/- mice 3 months after SHAM-operation (SHAM) or surgical reduced renal mass (RRM, n=6/group). Microvascular contractions were studied on a wire myograph. Cellular (ethidium: dihydroethidium) and mitochondrial (mitoSOX) ROS were measured by fluorescence microscopy. Mice with RRM had increased excretion of markers of oxidative stress, thromboxane, and microalbumin; increased plasma ET-1; and increased microvascular expression of p22(phox), cyclooxygenase-2, TP-Rs, preproendothelin and endothelin-A receptors, and increased arteriolar remodeling. They had increased contractions to U-46,619 (118 ± 3 versus 87 ± 6, P<0.05) and ET-1 (108 ± 5 versus 89 ± 4, P<0.05), which were dependent on cellular and mitochondrial ROS, cyclooxygenase-2, and TP-Rs. RRM doubled the ET-1-induced cellular and mitochondrial ROS generation (P<0.05). TP-R-/- mice with RRM lacked these abnormal structural and functional microvascular responses and lacked the increased systemic and the increased microvascular oxidative stress and circulating ET-1. In conclusion, RRM leads to microvascular remodeling and enhanced ET-1-induced cellular and mitochondrial ROS and contractions that are mediated by cyclooxygenase-2 products activating TP-Rs. Thus, TP-Rs can be upstream from enhanced ROS, ET-1, microvascular remodeling, and contractility and may thereby coordinate vascular dysfunction in chronic kidney disease.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  cyclooxygenase; mitochondria; oxidative stress; thromboxane; vascular remodeling

Mesh:

Substances:

Year:  2015        PMID: 25733239      PMCID: PMC4990073          DOI: 10.1161/HYPERTENSIONAHA.115.05244

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  53 in total

1.  Angiotensin II infusion alters vascular function in mouse resistance vessels: roles of O and endothelium.

Authors:  Dan Wang; Tina Chabrashvili; Lillian Borrego; Shakil Aslam; Jason G Umans
Journal:  J Vasc Res       Date:  2005-12-06       Impact factor: 1.934

2.  Daily administration of the TP receptor antagonist terutroban improved endothelial function in high-cardiovascular-risk patients with atherosclerosis.

Authors:  Pierre-François Lesault; Laurent Boyer; Gabriel Pelle; Ala Covali-Noroc; Dominique Rideau; Servais Akakpo; Emmanuel Teiger; Jean-Luc Dubois-Randé; Serge Adnot
Journal:  Br J Clin Pharmacol       Date:  2011-06       Impact factor: 4.335

3.  Myogenic responses of mouse isolated perfused renal afferent arterioles: effects of salt intake and reduced renal mass.

Authors:  En Yin Lai; Maristela L Onozato; Glenn Solis; Shakil Aslam; William J Welch; Christopher S Wilcox
Journal:  Hypertension       Date:  2010-03-01       Impact factor: 10.190

4.  Vasoconstrictor responses in thromboxane receptor knockout mice: tubuloglomerular feedback and ureteral obstruction.

Authors:  J Schnermann; T Traynor; H Pohl; D W Thomas; T M Coffman; J P Briggs
Journal:  Acta Physiol Scand       Date:  2000-01

Review 5.  Obesity paradox in end-stage kidney disease patients.

Authors:  Jongha Park; Seyed-Foad Ahmadi; Elani Streja; Miklos Z Molnar; Katherine M Flegal; Daniel Gillen; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Prog Cardiovasc Dis       Date:  2013-10-09       Impact factor: 8.194

6.  Thromboxane receptors in smooth muscle promote hypertension, vascular remodeling, and sudden death.

Authors:  Matthew A Sparks; Natalia A Makhanova; Robert C Griffiths; John N Snouwaert; Beverly H Koller; Thomas M Coffman
Journal:  Hypertension       Date:  2012-11-12       Impact factor: 10.190

7.  Enhanced contractility of renal afferent arterioles from angiotensin-infused rabbits: roles of oxidative stress, thromboxane prostanoid receptors, and endothelium.

Authors:  Dan Wang; Tina Chabrashvili; Christopher S Wilcox
Journal:  Circ Res       Date:  2004-04-29       Impact factor: 17.367

8.  Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.

Authors:  B Payson Oberg; Elizabeth McMenamin; F Lee Lucas; Ellen McMonagle; Jason Morrow; T Alp Ikizler; Jonathan Himmelfarb
Journal:  Kidney Int       Date:  2004-03       Impact factor: 10.612

9.  Response of rat thoracic aortic rings to thromboxane mimetic U-46,619: roles of endothelium-derived relaxing factor and thromboxane A2 release.

Authors:  W H Folger; D Lawson; C S Wilcox; J L Mehta
Journal:  J Pharmacol Exp Ther       Date:  1991-08       Impact factor: 4.030

10.  A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression.

Authors:  A Benigni; C Zoja; D Corna; S Orisio; L Longaretti; T Bertani; G Remuzzi
Journal:  Kidney Int       Date:  1993-08       Impact factor: 10.612

View more
  13 in total

Review 1.  Coronary microvascular disease as an early culprit in the pathophysiology of diabetes and metabolic syndrome.

Authors:  Hicham Labazi; Aaron J Trask
Journal:  Pharmacol Res       Date:  2017-07-09       Impact factor: 7.658

2.  Sympathetic Overactivity in CKD Disrupts Buffering of Neurotransmission by Endothelium-Derived Hyperpolarizing Factor and Enhances Vasoconstriction.

Authors:  Wei Cao; Liling Wu; Xiaodong Zhang; Jing Zhou; Jian Wang; Zhichen Yang; Huanjuan Su; Youhua Liu; Christopher S Wilcox; Fan Fan Hou
Journal:  J Am Soc Nephrol       Date:  2020-07-02       Impact factor: 10.121

3.  Hypercholesterolemia Impairs Nonstenotic Kidney Outcomes After Reversal of Experimental Renovascular Hypertension.

Authors:  Dong Sun; Zhi Chen; Alfonso Eirin; Xiang-Yang Zhu; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Am J Hypertens       Date:  2016-01-05       Impact factor: 2.689

4.  NRF2 prevents hypertension, increased ADMA, microvascular oxidative stress, and dysfunction in mice with two weeks of ANG II infusion.

Authors:  Cheng Wang; Zaiming Luo; Gabriella Carter; Anton Wellstein; Pedro A Jose; James Tomlinson; James Leiper; William J Welch; Christopher S Wilcox; Dan Wang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-11-22       Impact factor: 3.619

5.  P450 Eicosanoids and Reactive Oxygen Species Interplay in Brain Injury and Neuroprotection.

Authors:  Xuehong Liu; Catherine M Davis; Nabil J Alkayed
Journal:  Antioxid Redox Signal       Date:  2017-04-20       Impact factor: 8.401

6.  Downregulation of Thromboxane A2 Receptor Occurs Mainly via Nuclear Factor-KappaB Signaling Pathway in Rat Renal Artery.

Authors:  Yaping Zhang; Man Mi; Yan-Hua Xie; Si-Wang Wang; Lars Edvinsson; Cang-Bao Xu
Journal:  Adv Pharmacol Sci       Date:  2017-07-09

7.  Cyclooxygenase-2 Inhibition Limits Angiotensin II-Induced DNA Oxidation and Protein Nitration in Humans.

Authors:  Vincent Pialoux; Marc J Poulin; Brenda R Hemmelgarn; Daniel A Muruve; Erica N Chirico; Camille Faes; Darlene Y Sola; Sofia B Ahmed
Journal:  Front Physiol       Date:  2017-03-10       Impact factor: 4.566

8.  Endothelin-1-Induced Microvascular ROS and Contractility in Angiotensin-II-Infused Mice Depend on COX and TP Receptors.

Authors:  Christopher S Wilcox; Cheng Wang; Dan Wang
Journal:  Antioxidants (Basel)       Date:  2019-06-22

9.  Changes in arterial pressure and markers of nitric oxide homeostasis and oxidative stress following surgical correction of hydronephrosis in children.

Authors:  Ammar Al-Mashhadi; Antonio Checa; Nils Wåhlin; Tryggve Neveus; Magdalena Fossum; Craig E Wheelock; Birgitta Karanikas; Arne Stenberg; A Erik G Persson; Mattias Carlstrom
Journal:  Pediatr Nephrol       Date:  2017-12-01       Impact factor: 3.714

Review 10.  Prostaglandins in the pathogenesis of kidney diseases.

Authors:  Yuanyuan Li; Weiwei Xia; Fei Zhao; Zhaoying Wen; Aihua Zhang; Songming Huang; Zhanjun Jia; Yue Zhang
Journal:  Oncotarget       Date:  2018-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.